Hospital Acquired Infection (HAI) Control Markets

 
Online Download $4,500
Departmental Site License (one location, 10 users) $6,750
Global Site License $9,000
Published Feb 22, 2017 | 242 Pages | Pub ID: KLI15261546

Hospital Acquired Infection (HAI) Control Markets

Hospital Acquired Infection (HAI) Control Markets focuses on the market for preventing, testing, and treating infections in the healthcare environment. Major consideration is given to bacterial nosocomial infections because they are the most frequent type of infections spread in the healthcare delivery setting and the practical aspects of diagnosis and therapy are more meaningful based on a combination of medical and financial considerations. The report provides a market analysis for each of three areas: prevention (sterilization and disinfection equipment), testing, and treatment, detailing the following market data:
  • The Global Market for Hospital Infection Control, 2010-2021
  • The Global Market for Hospital Infection Prevention Equipment and Consumables (Sterilization/Disinfection), 2010-2021
  • The Global Market for Hospital Infection Prevention (Sterilization/Disinfection) Estimated Products Sales by Primary Geographic Region, 2010-2021 (United States, Europe, Rest of World, Total)
  • Market Value for Infection Prevention Equipment and Related Consumables by Product Type, 2016 (Medical Device/Instrument Sterilization, Wide-Area/Room Sterilization, Medical-grade Disinfection Solutions, Other Products, Total)
  • Market Value for Infection Prevention Equipment and Related Consumables by Technology, 2016 (Heat/Steam, Gas/Chemical, Ultrasound, Other, Total)
  • The Global Market for Hospital Infection Prevention (Sterilization/Disinfection), Leading Suppliers’ Shares, Estimates for 2016
  • The Global Market for Hospital Infection Testing/Diagnostics, 2010-2021
  • The Global Market for Hospital Infection Testing/Diagnostics, Estimated Products Sales by Primary Geographic Region, 2010-2021 (United States, Europe, Rest of World, Total)
  • The Global Market for Hospital Infection Testing/Diagnostics Leading Suppliers’ Shares Estimates for 2016
  • The Global Market for Hospital Infection Treatment, 2010-2021
  • The Global Market for Hospital Infection Treatment Estimated Products, Sales by Primary Geographic Region, 2010-2021 (United States, Europe, Rest of World, Total)
  • The Global Market for Hospital Infection Treatment, Leading Suppliers' Shares, Estimated Share for HAIs for 2016
  • Annual Sales of Select Antibacterial Products, 2016
  • The Global Market for Hospital Infection Control, Estimated Market Share by Segment, 2016 (Treatment, Prevention, Testing)
  • The Global Market for Hospital Infection Control Estimated Market Share by Facility Setting, 2016 (Hospitals, Outpatient Servicing Centers, Dialysis Centers, Nursing Homes, Community Clinics, Others)
  • The Global Market for Hospital Infection Control Estimated Market Share by Hospital Department, 2016 (ICU, Med/Surg, Pediatrics, Others)
  • The Global Market for Hospital Infection Control, Estimated Products Sales by Primary Geographic Region, 2010-2021 (United States, Europe, Rest of World, Total)
  • The Global Market for Hospital Infection Control, Estimated Product Sales by Geographic Region, 2010-2021 (United States, Europe, Rest of World)
  • The Global Market for Hospital Infection Control, Estimated Market Share by Geographic Region, 2016 (%) (United States, Europe, Rest of World)
  • The Global Market for Hospital Infection Control, Estimated Market Share by Region, 2016 (%) (Developed Europe, Emerging Europe, United States, Rest of World [Japan, India, Canada, Brazil, China, Mexico, Africa, Other Developed, Other Emerging])
  • Global Markets for HAI by Participant and Segment (Infection Prevention, Infection Diagnostics, Infection Treatment)
A nosocomial infection is a new infection that develops in a patient during hospitalization or during a stay at a health facility. It is usually defined as an infection that is identified at least forty-eight to seventy-two hours following admission, so infections incubating, but not clinically apparent, at admission are excluded. This type of infection is also known as a hospital-acquired infection (or, more generically, healthcare associated infection). The report provides the following data regarding nosocomial infections:
  • Frequency of the Most Common Nosocomial Infections
  • Market Value for Nosocomial Infection Diagnostics by Class, 2016 (Immunoassays, Microbial Identification / Antimicrobial Sensitivity (ID/AST), Molecular DNA, Total)
  • Market Value for Nosocomial Infection Diagnostics by Pathogen Target, 2016 (C. difficile Infections; MRSA Infections; Enterococcus, vancomycin-resistant; Enterobacteriaceae, carbapenem-resistant; M Tuberculosis; Others; Total)
  • Market Value for Nosocomial Infection Treatments by Class, 2016 (Quinolones, Glycopeptides, ß-lactamase inhibitors, Tetracyclines, Oxazolidinones, Macrolides, Carbapenems, Cephalosporins, Penicillins, Combinations, Others, Total)
  • Nosocomial Infection Drug Candidates by Class, 2016 (Quinolones, Glycopeptides, Aminoglycosides, Tetracyclines, Oxazolidinones, Macrolides, Pleuromutilins, Cephalosporins, Fabl inhibitors, Combinations, Others, Total)
  • Market Value for Nosocomial Infection Treatments by Pathogen Target, 2016 (ABSSSI, cUTI, MRSA Infections, HAP/VAP, C. Difficile Infections, Others, Total)
Hospital acquired infections share many of the challenges faced by the larger healthcare industry. Both challenges and industry trends are discussed in Hospital Acquired Infection (HAI) Control Markets, as well as market growth drivers and market growth inhibitors. One of the challenges facing the market is that increased attention to identification in the emergency department (ED) is needed to reduce risk and control exposure. With rapid identification, placing patients in isolation, whether they are colonized or infected, will likely make a difference in the resistance rates and spread of microorganisms in hospitalized patients.

The majority of competitive participation for healthcare infection control is in the United States and Europe. However, competition is steadily escalating in these areas, which is encouraging more participation in other regions such as Asia and Latin America. The report profiles important players in the current competitive landscape, including:
  • 3M
  • Abbott Laboratories
  • AbbVie
  • Advanced Sterilization Products
  • Alere
  • AstraZeneca
  • Bayer
  • Becton, Dickinson
  • Belimed
  • bioMérieux
  • Cantel Medical
  • Danaher
  • Ecolab
  • Getinge AB
  • GlaxoSmithKline
  • Merck & Co.
  • Pfizer, Inc.
  • Roche (F. Hoffman-La Roche, Ltd.)
  • Sakura Seiki, Co., Ltd.
  • Steris plc
  • TSO3
Market analysis in this report considers primarily the epidemiological considerations and the size of patient groups both in the United States and globally, where available. We have accumulated the most recent data available, understanding that virtually no organization does extensive studies on these applications on a regular basis. Many studies are highly localized and may only apply to a community, state or country (more often countries that are not a part of the major markets for nosocomial diagnostic and therapeutic products). In many instances, we have had to draw from broader epidemiologic data, that is, on data that reach outside of the hospital and primary care environment in order to construct a picture of the infection prevention, testing and treatment needs.

  • $924.00 Included
    •  
      $129.00 Included

    • $186.00 Included
      •   Frequency of the Most Common Nosocomial Infections
    •  
      $155.00 Included
    •  
      $117.00 Included

    • $109.00 Included
      •   Growth Drivers and Inhibitors

    • $126.00 Included
      •   The Global Market for Hospital Infection Control, 2010-2021
      •   Global Market for Hospital Infection Control, 2010-2021: Market Continues to Show Moderate Growth over Period
    •  
      $102.00 Included

  • $3,244.00 Included

    • $212.00 Included
      •  
        $104.00 Included
      •  
        $107.00 Included
    •  
      $93.00 Included

    • $1,208.00 Included
      •  
        $239.00 Included
      •  
        $165.00 Included
      •  
        $105.00 Included
      •  
        $112.00 Included
      •  
        $93.00 Included
      •  
        $93.00 Included
      •  
        $93.00 Included
      •  
        $222.00 Included
      •  
        $93.00 Included
      •  
        $93.00 Included
      •  
        $93.00 Included
      •  
        $93.00 Included

      • $93.00 Included
        •   Global Population at Risk for Serious Bacterial Infections, Secondary to Chronic Diseases by Selected Geographical Region

    • $255.00 Included
      •   The Global Population, 2005-2050 (in millions)
      •   Global Population Trends Age 65+, 2000-2050

      • $93.00 Included
        •   U.S. Hospital Admissions and Percent of Hospital Acquired Infections (HAIs)
        •   European Union Hospital Admissions and Percent of Hospital Acquired Infections (HAIs)
      •  
        $97.00 Included
    •  
      $93.00 Included
    •  
      $155.00 Included
    •  
      $93.00 Included
    •  
      $103.00 Included

    • $476.00 Included
      •   U.S. States ACA HAI Prevention Infrastructure Funding Awards, 2013-2016

    • $93.00 Included
      •   U.S. Department of Health & Human Services Fiscal Budget, 2015-2017 ($millions)

    • $255.00 Included
      •   U.S. Hospital Acquired Infection Standardized Infection Ratio (SIR), 2010-2014
      •   U.S. Hospital Acquired Infection Standardized Infection Ratio (SIR) 2012 through 2014: MRSA, CLABSI, and CAUTI Infections Down; SSI and C. Diff Infections Up
    •  
      $143.00 Included

    • $222.00 Included
      •  
        $93.00 Included
      •  
        $140.00 Included

  • $3,041.00 Included

    • $346.00 Included
      •   Methods of Sterilization and Disinfection

    • $312.00 Included
      •   The Global Market for Hospital Infection Prevention Equipment and Consumables (Sterilization/Disinfection), 2010-2021

      • $124.00 Included
        •   The Global Market for Hospital Infection Prevention (Sterilization/Disinfection) Estimated Products Sales by Primary Geographic Region, 2010-2021
      •  
        $93.00 Included

    • $966.00 Included
      •  
        $186.00 Included
      •  
        $93.00 Included
      •  
        $93.00 Included

      • $502.00 Included
        •   Market Value for Infection Prevention Equipment and Related Consumables by Product Type, 2016
      •  
        $150.00 Included

    • $93.00 Included
      •   Market Value for Infection Prevention Equipment and Related Consumables by Technology, 2016

    • $162.00 Included
      •  
        $141.00 Included

    • $806.00 Included
      •  
        $93.00 Included

      • $454.00 Included
        •   Summary of Advantages and Disadvantages of Chemical Agents Used as Chemical Sterilants or as High-Level Disinfectants
        •   Comparison of the Characteristics of Selected Chemicals Used as High-Level Disinfectants or Chemical Sterilants
      •  
        $149.00 Included

      • $115.00 Included
        •   Comparison of the Characteristics of Selected Hospital Disinfectants for General Disinfection of Environmental Surfaces

    • $273.00 Included

      • $263.00 Included
        •   Developments, Healthcare Infection Prevention

    • $156.00 Included
      •   The Global Market for Hospital Infection Prevention (Sterilization/Disinfection), Leading Suppliers' Shares, Estimates for 2016

  • $3,301.00 Included
    •  
      $93.00 Included

    • $302.00 Included
      •   The Global Market for Hospital Infection Testing/Diagnostics, 2010-2021

      • $152.00 Included
        •   The Global Market for Hospital Infection Testing/Diagnostics, Estimated Products Sales by Primary Geographic Region, 2010-2021

    • $794.00 Included
      •  
        $197.00 Included
      •  
        $93.00 Included
      •  
        $93.00 Included
      •  
        $93.00 Included
      •  
        $93.00 Included
      •  
        $93.00 Included
      •  
        $93.00 Included
      •  
        $93.00 Included
      •  
        $93.00 Included
      •  
        $113.00 Included

      • $93.00 Included
        •   Market Value for Nosocomial Infection Diagnostics by Class, 2016

    • $1,758.00 Included
      •   Tested Samples, Pathogens Isolated by Infection Type Infection Type Isolated Pathogen Distribution (%)
      •  
        $93.00 Included
      •  
        $93.00 Included
      •  
        $93.00 Included
      •  
        $203.00 Included
      •  
        $165.00 Included
      •  
        $93.00 Included
      •  
        $773.00 Included

      • $343.00 Included
        •   Significant Approvals for Detecting Serious Healthcare Infections
        •   HAI Test Approvals* in the U.S. by Year and Type, 2000-2016
        •   Distribution of Diagnostic Test Approvals with HAI Indications by Pathogen, All Approvals, 2000-2016
        •   Market Value for Nosocomial Infection Diagnostics by Pathogen Target, 2016

    • $145.00 Included
      •   Ongoing Developments, Healthcare Infection Testing
      •   Pathogen/Infection Detection Trials by Type

    • $233.00 Included
      •   The Global Market for Hospital Infection Testing/Diagnostics Leading Suppliers' Shares Estimates for 2016

  • $4,146.00 Included
    •  
      $93.00 Included

    • $266.00 Included
      •   The Global Market for Hospital Infection Treatment, 2010-2021

      • $98.00 Included
        •   The Global Market for Hospital Infection Treatment Estimated Products, Sales by Primary Geographic Region, 2010-2021

    • $158.00 Included
      •  
        $93.00 Included
      •  
        $93.00 Included
      •  
        $93.00 Included
      •  
        $93.00 Included
      •  
        $93.00 Included
      •  
        $93.00 Included

    • $449.00 Included
      •  
        $93.00 Included
      •  
        $93.00 Included
      •  
        $184.00 Included
      •  
        $93.00 Included
      •  
        $93.00 Included
      •  
        $93.00 Included
      •  
        $93.00 Included
      •  
        $93.00 Included
      •  
        $93.00 Included

    • $110.00 Included
      •   Market Value for Nosocomial Infection Treatments by Class, 2016
      •   Nosocomial Infection Drug Candidates by Class, 2016

    • $241.00 Included

      • $93.00 Included
        •   CDER NME NDAs/BLAs Filings and Approvals as of 12/9/15

    • $1,655.00 Included
      •  
        $187.00 Included
      •  
        $161.00 Included

      • $1,266.00 Included
        •   Antibiotics with Difficult Penetration
        •   Market Value for Nosocomial Infection Treatments by Pathogen Target, 2016

    • $565.00 Included
      •   New Developments, Healthcare Infection Treatments, as of December 2016
      •   Infection Treatments in Development by Phase, as of December 2016
      •   Infection Treatment Drugs in Development by Route of Administration, as of December 2016
      •  
        $93.00 Included

    • $678.00 Included
      •   The Global Market for Hospital Infection Treatment, Leading Suppliers' Shares, Estimated Share for HAIs for 2016
      •   Select Treatment Options for Serious Bacterial Infections (Type, Brand, and Manufacturer)

      • $93.00 Included
        •   Annual Sales of Select Antibacterial Products, 2016

  • $465.00 Included
    •  
      $93.00 Included

    • $417.00 Included
      •   The Global Market for Hospital Infection Control, 2010-2021
      •   The Global Market for Hospital Infection Control, Estimated Market Share by Segment, 2016

      • $93.00 Included
        •   The Global Market for Hospital Infection Control Estimated Market Share by Facility Setting, 2016
        •   The Global Market for Hospital Infection Control Estimated Market Share by Hospital Department, 2016

      • $116.00 Included
        •   The Global Market for Hospital Infection Control, Estimated Products Sales by Primary Geographic Region, 2010-2021
        •   The Global Market for Hospital Infection Control, Estimated Product Sales by Geographic Region, 2010-2021
        •   The Global Market for Hospital Infection Control, Estimated Market Share by Geographic Region, 2016 (%)

      • $101.00 Included
        •   Developed vs. Emerging Markets
        •   The Global Market for Hospital Infection Control, Estimated Market Share by Region, 2016 (%)

  • $2,428.00 Included

    • $93.00 Included
      •   Global Markets for HAI by Participant and Segment (Infection Prevention, Infection Diagnostics, Infection Treatment): HAI Treatment Participants Show Strong Performance in 2016

    • $99.00 Included
      •   3M Company Corporate Summary
      •  
        $93.00 Included
      •  
        $93.00 Included

    • $138.00 Included
      •   Abbott Laboratories Corporate Summary
      •  
        $93.00 Included
      •  
        $93.00 Included

    • $102.00 Included
      •   AbbVie Corporate Summary
      •  
        $93.00 Included
      •  
        $93.00 Included

    • $93.00 Included
      •   Advanced Sterilization Products Corporate Summary
      •  
        $93.00 Included
      •  
        $93.00 Included

    • $117.00 Included
      •   Alere Corporate Summary
      •  
        $93.00 Included
      •  
        $93.00 Included

    • $102.00 Included
      •   AstraZeneca Corporate Summary
      •  
        $93.00 Included
      •  
        $93.00 Included

    • $135.00 Included
      •   Bayer Corporate Summary
      •  
        $93.00 Included
      •  
        $93.00 Included

    • $119.00 Included
      •   Becton, Dickinson Corporate Summary
      •  
        $93.00 Included
      •  
        $93.00 Included

    • $93.00 Included
      •   Belimed Corporate Summary
      •  
        $93.00 Included
      •  
        $93.00 Included

    • $150.00 Included
      •   bioMérieux Corporate Summary
      •  
        $93.00 Included
      •  
        $93.00 Included

    • $144.00 Included
      •   Cantel Medical Corporate Summary
      •  
        $93.00 Included
      •  
        $93.00 Included

    • $155.00 Included
      •   Danaher Corporate Summary
      •  
        $93.00 Included
      •  
        $93.00 Included

    • $93.00 Included
      •   Ecolab Corporate Summary
      •  
        $93.00 Included
      •  
        $93.00 Included

    • $116.00 Included
      •   Getinge AB Corporate Summary
      •  
        $93.00 Included
      •  
        $93.00 Included

    • $103.00 Included
      •   GlaxoSmithKline Corporate Summary
      •  
        $93.00 Included
      •  
        $93.00 Included

    • $120.00 Included
      •   Merck Corporate Summary
      •  
        $93.00 Included
      •  
        $93.00 Included

    • $120.00 Included
      •   Pfizer Corporate Summary
      •  
        $93.00 Included
      •  
        $93.00 Included

    • $113.00 Included
      •   F. Hoffman-La Roche, Ltd. Corporate Summary
      •  
        $93.00 Included
      •  
        $93.00 Included

    • $93.00 Included
      •   Sakura Seiki Corporate Summary
      •  
        $93.00 Included

    • $130.00 Included
      •   Steris Corporate Summary
      •  
        $93.00 Included
      •  
        $93.00 Included

    • $119.00 Included
      •   TSO3 Corporate Summary
      •  
        $93.00 Included
      •  
        $93.00 Included

  • $240.00 Included
    •   List of Participants

In this report, {{keyword[keywordTextProperty]}} appears {{keyword[keywordCountProperty]}} times. {{searchResults.STATRESULT.SUMMARY.KW[keywordTextProperty]}} appears {{searchResults.STATRESULT.SUMMARY.KW[keywordCountProperty]}} times.

We were unable to search inside this report.

Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).

Please note that your term must be at least three characters long and numbers will be blocked by the # sign.